Ron Bentsur
2012 - Keryx Biopharmaceuticals
In 2012, Ron Bentsur earned a total compensation of $710.1K as Former Chief Executive Officer at Keryx Biopharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,500 |
|---|---|
| Option Awards | $124,084 |
| Salary | $300,000 |
| Stock Awards | $83,490 |
| Total | $710,074 |
Bentsur received $300K in salary, accounting for 42% of the total pay in 2012.
Bentsur also received $202.5K in non-equity incentive plan, $124.1K in option awards and $83.5K in stock awards.
Rankings
In 2012, Ron Bentsur's compensation ranked 7,515th out of 11,487 executives tracked by ExecPay. In other words, Bentsur earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,515 out of 11,487 | 35th |
Division Manufacturing | 2,705 out of 4,253 | 36th |
Major group Chemicals And Allied Products | 700 out of 1,203 | 42nd |
Industry group Drugs | 489 out of 925 | 47th |
Industry Pharmaceutical Preparations | 383 out of 700 | 45th |
Source: SEC filing on April 30, 2015.
Bentsur's colleagues
We found one more compensation record of an executive who worked with Ron Bentsur at Keryx Biopharmaceuticals in 2012.
2012
James Oliviero
Keryx Biopharmaceuticals